EVH is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 available, especially since the user is unwilling to wait for a better entry. The stock is showing a weak technical setup, there is no fresh news catalyst, and financial data is unavailable to confirm fundamental improvement. While analyst targets were recently raised and the stock may have upside versus the current price, the current evidence is not strong enough to make it an immediate buy.
EVH is in a bearish technical structure. The MACD histogram is negative at -0.0658 and still contracting, RSI_6 is neutral at 52.322, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price at 3.90 is below the pivot of 3.977 and below resistance levels R1 at 4.242 and R2 at 4.406, while support sits at 3.711 and 3.547. This suggests the stock is still under pressure and lacks a clear bullish breakout trend. The short-term pattern estimate shows only modest upside probabilities, not a strong trend reversal.

["Citi raised EVH's price target to $5.50 from $4 and maintained a Buy rating.", "Canaccord raised its price target to $6 from $5 and kept a Buy rating.", "Analysts noted the company continues to win new business despite mixed Q1 results.", "Options flow is somewhat bullish based on a low put-call volume ratio."]
["No news in the recent week, so there is no fresh event-driven catalyst.", "Technical trend remains bearish with moving averages stacked negatively.", "MACD remains below zero and weakening.", "Hedge funds and insiders are both neutral with no meaningful buying trend.", "No recent congress trading data was available.", "Financial snapshot data is unavailable, so recent quarter fundamental momentum cannot be confirmed."]
Latest quarter financials were not provided due to an error, so there is no usable quarterly revenue or earnings snapshot to evaluate. Because the latest quarter season is unavailable, I cannot confirm growth acceleration or margin improvement from the supplied data.
Recent analyst trend is positive: Citi increased its target to $5.50 from $4 and Canaccord raised its target to $6 from $5, with both firms maintaining Buy ratings. This shows Wall Street pros are constructive on the name and see upside from the current $3.90 price. The bull case is that EVH may recover toward higher targets if execution improves. The bear case is that the current price action and lack of fresh catalysts do not yet confirm that recovery.